XERS Xeris Biopharma Holdings, Inc.
Price Chart
Executive Summary
A cluster of insider selling at Xeris Biopharma, totaling $192K in open-market sales by two directors and an officer, occurred alongside large non-cash equity grants to four directors. The sales represent ~0.017% of the $1.1B market cap, a trivial amount, and are likely liquidity-driven following the vesting of restricted stock grants. No material bearish signal is present.
Key Financial Metrics
Actionable Insight
The insider selling is trivial in size and likely tied to equity grant vesting, not a negative signal. Monitor for any upcoming earnings or pipeline catalysts that could move the stock, but this cluster alone does not warrant action.
Key Facts
- Three insiders sold a total of $192K in open-market sales: Director John Johnson ($91K), Director Dawn Halkuff ($122K), and Officer Beth Hecht ($101K).
- Four directors received non-cash equity grants totaling ~$609K in value (at $6.15/share) and additional zero-value grants.
- Total open-market sales represent ~0.017% of the $1.1B market cap, well below the 0.1% threshold for materiality.
- Sales occurred on the same day as large equity grants, suggesting a routine pattern of selling to cover tax obligations or diversify after vesting.
Financial Impact
Open-market sales of $192K, or ~0.017% of market cap, are immaterial relative to company size.
Risk Factors
- No material risk identified from this insider activity; the cluster is routine and non-informative.
- The company's historical insider report win rate is 50% with negative average alpha, suggesting past cluster reads have not been predictive.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-XERS-1780697908162 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
3d ago
|
Institutional Cluster
| $6.93 awaiting T+1 | awaiting T+1 | — | $6.79 (−2.02%) |
|
Jun 5, 2026
9d ago
|
Insider Cluster
| $6.17 awaiting T+1 | awaiting T+1 | — | $6.79 (+10.05%) |
|
Jun 5, 2026
9d ago
|
Insider Cluster
| $6.17 awaiting T+1 | awaiting T+1 | — | $6.79 (+10.05%) |
|
Jun 4, 2026
10d ago
|
144
| $6.17 awaiting T+1 | awaiting T+1 | — | $6.79 (+10.05%) |
|
Jun 3, 2026
11d ago
|
144
| $6.15 $6.18 | ▲ +0.49% | ▲ +3.06% | $6.79 (+10.41%) |
|
Feb 27, 2026
15w ago
|
8-K
| $6.12 $6.02 | ▼ −1.63% | ▼ −1.69% | $6.79 (+10.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access